Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Short term Debt: 2021-2022

Historic Short term Debt for Cardiol Therapeutics (CRDL) over the last 1 years, with Sep 2022 value amounting to $1.5 million.

  • Cardiol Therapeutics' Short term Debt was N/A to $1.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Cardiol Therapeutics reported Short term Debt of $1.5 million as of Q3 2022, which was down 48.19% from $2.9 million recorded in Q2 2022.
  • In the past 5 years, Cardiol Therapeutics' Short term Debt registered a high of $5.3 million during Q4 2021, and its lowest value of $1.5 million during Q3 2022.
  • In the last 2 years, Cardiol Therapeutics' Short term Debt had a median value of $3.2 million in 2022 and averaged $3.3 million.